Bristol Myers Squibb to Buy RayzeBio for $4.1 Billion
Wall Street Journal
Bristol Myers Squibb has struck a $4.1 billion deal to buy radiopharmaceutical therapeutics company RayzeBio.
https://www.wsj.com/articles/bristol-myers-squibb-to-buy-rayzebio-for-4-1-billion-ad509029